Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring.
作者信息
Favaloro Emmanuel J, Lippi Giuseppe
机构信息
Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine, and Movement, University of Verona, Verona, Italy.
出版信息
Semin Thromb Hemost. 2020 Apr;46(3):379-382. doi: 10.1055/s-0040-1709498. Epub 2020 Apr 12.
Abstract
摘要
相似文献
1
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring.新型冠状病毒肺炎患者最小实验室检测组合的建议：预后监测的潜力
Semin Thromb Hemost. 2020 Apr;46(3):379-382. doi: 10.1055/s-0040-1709498. Epub 2020 Apr 12.
2
Our recommendations for acute management of COVID-19.我们对新型冠状病毒肺炎急性处理的建议。
Crit Care. 2020 May 8;24(1):207. doi: 10.1186/s13054-020-02930-6.
3
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis.一名患有严重急性溃疡性结肠炎的患者发生了致命的新冠肺炎肺炎病例。
Gut. 2020 Jun;69(6):1148-1149. doi: 10.1136/gutjnl-2020-321183. Epub 2020 Apr 3.
4
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.感染新型冠状病毒后发生的致死性吉兰-巴雷综合征。
Neurologia (Engl Ed). 2020 May;35(4):265-267. doi: 10.1016/j.nrl.2020.04.004. Epub 2020 Apr 18.
5
Clinical findings in a patient with haemophilia A affected by COVID-19.一名甲型血友病患者感染新型冠状病毒肺炎的临床发现。
Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13.
6
Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients.2019冠状病毒病在慢性血栓栓塞性肺动脉高压患者中的意外良好病程
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):749-752. doi: 10.1016/j.arbres.2020.06.004. Epub 2020 Jun 26.
7
Underpromise, overdeliver.少承诺，多兑现。
Science. 2020 Mar 27;367(6485):1405. doi: 10.1126/science.abb8492. Epub 2020 Mar 23.
8
COVID-19 induced systemic thrombosis.新冠病毒感染引发的全身性血栓形成。
Med Clin (Barc). 2020 Sep 25;155(6):278. doi: 10.1016/j.medcli.2020.05.025. Epub 2020 Jul 18.
9
Could COVID-19 represent a negative prognostic factor in patients with stroke?新型冠状病毒肺炎（COVID-19）会成为中风患者的不良预后因素吗？
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1115-1116. doi: 10.1017/ice.2020.146. Epub 2020 Apr 20.
10
Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection.胃肠道症状作为严重急性呼吸综合征冠状病毒2感染的首发非典型表现。
Pol Arch Intern Med. 2020 Apr 30;130(4):338-339. doi: 10.20452/pamw.15278. Epub 2020 Apr 3.
引用本文的文献
1
Critical biomarkers in the battle against COVID-19: unveiling thrombotic risks and predictive indicators in Syrian hospitals.抗击新冠疫情中的关键生物标志物：揭示叙利亚医院的血栓形成风险和预测指标
Ann Med Surg (Lond). 2025 Mar 20;87(8):4803-4810. doi: 10.1097/MS9.0000000000003168. eCollection 2025 Aug.
2
Vitamin D status in hospitalized COVID‑19 patients is associated with disease severity and IL-5 production.住院 COVID-19 患者的维生素 D 状况与疾病严重程度和 IL-5 产生有关。
Virol J. 2023 Sep 13;20(1):212. doi: 10.1186/s12985-023-02165-1.
3
The role of laboratory testing in hospitalised and critically ill COVID-19-positive patients.实验室检测在新冠病毒检测呈阳性的住院及重症患者中的作用。
South Afr J Crit Care. 2020 Jul 30;36(1). doi: 10.7196/SAJCC.2020.v36i1.447. eCollection 2020.
4
The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients.严重急性呼吸综合征冠状病毒2型患者中抗中性粒细胞胞浆抗体和抗磷脂抗体的存在：苏丹患者的病例对照研究
Interdiscip Perspect Infect Dis. 2022 Dec 15;2022:6511198. doi: 10.1155/2022/6511198. eCollection 2022.
5
Choosing which in-hospital laboratory tests to target for intervention: a scoping review.选择针对干预的院内实验室检测：范围综述。
Clin Chem Lab Med. 2022 Nov 22;61(3):388-401. doi: 10.1515/cclm-2022-0910. Print 2023 Feb 23.
6
COVID-19 associated coagulopathy and thrombosis in cancer.COVID-19 相关的癌症合并症与血栓
Thromb Res. 2022 May;213 Suppl 1:S72-S76. doi: 10.1016/j.thromres.2021.12.006. Epub 2022 May 26.
7
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.心脏生物酶在预测2019冠状病毒病心血管结局中的作用
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
8
A robust and parsimonious machine learning method to predict ICU admission of COVID-19 patients.一种用于预测新冠肺炎患者入住重症监护病房的强大且简约的机器学习方法。
Med Biol Eng Comput. 2022 Mar 30:1-13. doi: 10.1007/s11517-022-02543-x.
9
Lipoprotein(a) in COVID-19: Genetics and inflammation collide.新冠病毒感染中的脂蛋白(a)：遗传学与炎症的碰撞
Atherosclerosis. 2022 Apr;347:77-78. doi: 10.1016/j.atherosclerosis.2022.03.013. Epub 2022 Mar 12.
10
Changes of Routine Hematological Parameters in COVID-19 Patients: Correlation with Imaging Findings, RT-PCR and Outcome.新型冠状病毒肺炎患者血常规参数变化：与影像学表现、逆转录聚合酶链反应及预后的相关性
Iran J Pathol. 2022 Winter;17(1):37-47. doi: 10.30699/IJP.2021.533645.2675. Epub 2021 Dec 15.
本文引用的文献
1
A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection.宿主防御的捍卫者：感染导致血小板功能障碍和耗竭的一般性大规模原因。
Semin Thromb Hemost. 2020 Apr;46(3):302-319. doi: 10.1055/s-0040-1708827. Epub 2020 Apr 12.
2
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.D-二聚体与2019冠状病毒病的严重程度相关：一项汇总分析。
Thromb Haemost. 2020 May;120(5):876-878. doi: 10.1055/s-0040-1709650. Epub 2020 Apr 3.
3
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.
4
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
5
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Which lessons shall we learn from the 2019 novel coronavirus outbreak?我们应从2019年新型冠状病毒疫情中学到哪些教训？
Ann Transl Med. 2020 Feb;8(3):48. doi: 10.21037/atm.2020.02.06.
8
Laboratory abnormalities in patients with COVID-2019 infection.2019冠状病毒病感染患者的实验室异常情况。
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. doi: 10.1515/cclm-2020-0198.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
Zotero 插件